SEC Form 4 · accession 0001513162-16-000735
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Kumar
Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 2:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 29, 2016 | P | 1,000 | $2.40 | A | 103,408 | D | |
| Common Stock | Mar 1, 2016 | P | 1,000 | $2.52 | A | 104,408 | D |
Table II — derivative securities
No Table II lines on this filing.